Mutations in phosphatase and tensin homolog (PTEN) which regulates PI3‐kinase activity, have been reported in various human malignancies, including melanoma, glioblastoma, endometrial and prostate tumors (Whang et al., 1998[39]). The gene discussed is PTEN; the disease is prostate neoplasm.